KinDex Pharmaceuticals launches with Series A Funding
Biotechnology company KinDex Pharmaceuticals has secured a $5 million Series A funding backed by venture capital firm Polaris Partners. KinDex Pharmaceuticals was formed by the reorganization of KinDex Therapeutics in parallel with the investment.
25 March 2014•2 mins read
